Blood test on hyperacute phase of exertional heatillness

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220302

Enrollment

400

Registered

2017-07-05

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

exertional heatillness

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with symptoms of heatillness on hyperacute phase 2)Patients who have blood tests and treatments immediately after visiting clinic

Exclusion criteria

Exclusion criteria: 1)Patients with infective disease 2)Patients who visit clinic over 30 minutes later after having symptoms

Design outcomes

Primary

Measure	Time frame
renal function	—

Secondary

Measure	Time frame
electrolyte,blood sugar level,inflammatry markers	—

Countries

Japan

Contacts

Public ContactSatoko Inoue

Clinic of Japan Police Personnel Mutual Aid Association(Hyogo branch)

inoue-mikakita@outlook.jp+81-797-23-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026